Negative pAKT | Positive pAKT | |||||
---|---|---|---|---|---|---|
Total | n | % | n | % | P | |
NO, patients | 36 | 22 | 61 | 14 | 39 | |
Sex | Male | 10 | 45 | 6 | 43 | 0.577 |
Female | 12 | 55 | 8 | 57 | ||
Age | < 60 years | 15 | 68 | 10 | 71 | 0.569 |
≥ 60 years | 7 | 32 | 4 | 29 | ||
Median [range] | 56 [30-72] | 52 [34-68] | 0.575 | |||
Lactate dehydrogenase | N | 19 | 86 | 8 | 57 | 0.03 |
>N | 2 | 9 | 6 | 43 | ||
Unknown | 1 | 5 | 0 | 0 | ||
Performance status | 0 | 7 | 32 | 2 | 14 | 0.045 |
1 | 0 | 0 | 3 | 22 | ||
Unknown | 15 | 68 | 9 | 64 | ||
B symptoms | 0 | 5 | 23 | 4 | 29 | 0.601 |
1 | 4 | 18 | 4 | 29 | ||
Unknown | 13 | 59 | 6 | 42 | ||
Ann Arabor stage | I-II | 7 | 32 | 2 | 14 | 0.254 |
III-IV | 15 | 68 | 11 | 79 | ||
Unknown | 0 | 0 | 1 | 7 | ||
Adenopathy | 0-3 | 14 | 64 | 7 | 50 | 0.282 |
4 or more | 6 | 27 | 6 | 43 | ||
Unknown | 2 | 9 | 1 | 7 | ||
Hemoglobin | ≥ 12 g/dl | 13 | 59 | 9 | 64 | 0.684 |
< 12 g/dl | 3 | 14 | 2 | 14 | ||
Unknown | 6 | 27 | 3 | 22 | ||
β2 microglobulin | N | 9 | 41 | 5 | 36 | 0.306 |
> N | 4 | 18 | 5 | 36 | ||
Unknown | 9 | 41 | 4 | 28 | ||
Bone marrow involvement | 0 | 9 | 41 | 7 | 50 | 0.58 |
1 | 10 | 45 | 7 | 50 | ||
Unknown | 3 | 14 | 0 | 0 | ||
FLIPI | 0-1 | 3 | 14 | 1 | 7 | 0.390 |
2 | 7 | 32 | 4 | 29 | ||
≥ 3 | 4 | 18 | 6 | 43 | ||
Unknown | 8 | 36 | 3 | 21 | ||
Follow up (months) | Median [range] | 90 [9-200] | 97 [50-200] | 0.687 |